NYSE:DOCS

Doximity (DOCS) Stock Price, News & Analysis

Doximity logo
$30.75 -0.36 (-1.14%)
Closing price 11/18/2026 03:59 PM Eastern
Extended Trading
$31.00 +0.24 (+0.78%)
As of 08:55 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Doximity Stock (NYSE:DOCS)

Advanced

Key Stats

Today's Range
$30.15
▼
$31.85
50-Day Range
$24.80
▼
$34.64
52-Week Range
$17.15
▼
$51.85
Volume
2.27 million shs
Average Volume
2.39 million shs
Market Capitalization
$5.49 billion
P/E Ratio
42.71
Dividend Yield
N/A
Price Target
$30.59
Consensus Rating
Hold

Company Overview

Doximity, Inc. operates a digital platform designed for medical professionals, including physicians and other clinicians. Its services support professional networking, medical news and research discovery, career development, and communication among healthcare professionals.

The company also offers clinical workflow tools, including Doximity Dialer, which enables clinicians to make calls and conduct video visits using a work number, as well as digital fax and document services. Doximity provides marketing and recruitment solutions to healthcare organizations and life sciences companies.

Founded in 2010, Doximity primarily serves the U.S. healthcare market. The company was co-founded by Jeff Tangney, who serves as its chief executive officer.

AI Generated. May Contain Errors.

Doximity Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
55th Percentile Overall Score

DOCS MarketRank™: 
2.757534246575 of 5 stars

Doximity scored higher than 55% of companies evaluated by MarketBeat, and ranked 993rd out of 1,704 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Doximity has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on no strong buy ratings, 8 buy ratings, 14 hold ratings, and 3 sell ratings.

  • Upside/Downside

    The consensus price target for Doximity is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Doximity has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Doximity's stock forecast and price target.
  • Earnings Growth

    Earnings for Doximity are expected to grow by 23.61% in the coming year, from $0.72 to $0.89 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Doximity is 42.71, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.06.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Doximity is 42.71, which means that it is trading at a more expensive P/E ratio than the Healthcare sector average P/E ratio of about 32.95.

  • Price to Earnings Growth Ratio

    Doximity has a PEG Ratio of 33.31. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Doximity has a P/B Ratio of 5.91. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    5.71% of the float of Doximity has been sold short.
  • Short Interest Ratio / Days to Cover

    Doximity has a short interest ratio ("days to cover") of 2.68, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Doximity has recently decreased by 23.54%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Doximity does not currently pay a dividend.

  • Dividend Growth

    Doximity does not have a long track record of dividend growth.

  • News Sentiment

    Doximity has a news sentiment score of 0.19. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.38 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 17 news articles for Doximity this week, compared to 8 articles on an average week.
  • Search Interest

    6 people have searched for DOCS on MarketBeat in the last 30 days. This is an increase of 20% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Doximity insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $801,442.00 in company stock.

  • Percentage Held by Insiders

    31.80% of the stock of Doximity is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    87.19% of the stock of Doximity is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Doximity's insider trading history.
Receive DOCS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Doximity and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DOCS Stock News Headlines

Insider Selling: Doximity (NYSE:DOCS) CAO Sells $84,041.13 in Stock
My $247 scanner for $7
Bill Poulos is cutting the price of his $247 Instant Scanner to $7 for Black Friday. It's a one-time payment that covers a full year, with no subscription and no re-bills. Every night after the close, the scanner screens nearly a thousand of America's biggest stocks. It returns a short list of qualifying setups with the exact buy price next to each one. There's nothing to install. If you decide it's not for you, you get the $7 back and keep the scanner for the year.tc pixel
See More Headlines

DOCS Stock Analysis - Frequently Asked Questions

Doximity's stock was trading at $44.26 at the beginning of 2026. Since then, DOCS shares have decreased by 30.5% and is now trading at $30.7540.

Doximity, Inc. (NYSE:DOCS) announced its quarterly earnings data on Thursday, November, 5th. The company reported $0.36 EPS for the quarter, beating the consensus estimate of $0.19 by $0.17. The firm's revenue for the quarter was up 3.6% compared to the same quarter last year.
Read the conference call transcript
.

Doximity's board authorized a stock buyback plan on Thursday, February 5th 2026, which authorizes the company to buy back $500 million in shares, according to EventVestor. This means that the company could reacquire up to 8% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company's board of directors believes its stock is undervalued.

Doximity (DOCS) raised $501 million in an initial public offering (IPO) on Thursday, June 24th 2021. The company issued 23,300,000 shares at $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs and J.P. Morgan Securities served as the underwriters for the IPO and Piper Sandler, William Blair, Canaccord and Raymond James were co-managers.

Doximity's top institutional shareholders include State Street Corp (2.32%), Assenagon Asset Management S.A. (0.57%), Algert Global LLC (0.56%) and Goldman Sachs Group Inc. (0.47%). Insiders that own company stock include Anna Bryson, Craig Overpeck, Siddharth Sitaram, Kira Scherer Wampler, Watkin Phoebe L Yang, Regina M Benjamin and Timothy S Cabral.
View institutional ownership trends
.

Shares of DOCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Doximity investors own include NVIDIA (NVDA), CrowdStrike (CRWD), Advanced Micro Devices (AMD), Tesla (TSLA), Palantir Technologies (PLTR), PayPal (PYPL) and Walt Disney (DIS).

Company Calendar

Last Earnings
11/05/2026
Today
11/19/2026
Fiscal Year End
3/31/2027

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Healthcare Technology
Sub-Industry
Healthcare Technology
Current Symbol
NYSE:DOCS
Previous Symbol
NASDAQ:DOCS
CIK
1516513
Fax
N/A
Employees
880
Year Founded
2010

Price Target and Rating

High Price Target
$50.00
Low Price Target
$18.00
Potential Upside/Downside
-0.5%
Consensus Rating
Hold
Rating Score (0-4)
2.20
Research Coverage
25 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.72
Trailing P/E Ratio
42.71
Forward P/E Ratio
34.56
P/E Growth
33.31
Net Income
$196.05 million
Net Margins
21.12%
Pretax Margin
30.78%
Return on Equity
15.80%
Return on Assets
13.38%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.37
Quick Ratio
6.37

Sales & Book Value

Annual Sales
$644.86 million
Price / Sales
8.51
Cash Flow
$1.23 per share
Price / Cash Flow
25.10
Book Value
$5.20 per share
Price / Book
5.91

Miscellaneous

Outstanding Shares
178,410,000
Free Float
121,675,000
Market Cap
$5.49 billion
Optionable
Optionable
Beta
1.29

Social Links

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (NYSE:DOCS) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners